Blood – December 3, 2009

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Some see inhibitors as a lifetime of tests, bleeds, and complications.
Novo Nordisk helps them see a lifetime of possibilities.

Click on image to view ad details and full-size version on AdPharm.

To see all of this brand’s ads on AdPharm, click here

Click on image to view ad details and full-size version on AdPharm

Click on image to view ad details and full-size version on AdPharm

For your patients with chronic iron overload due to blood transfusions
Chelate with Exjade to help remove excess iron

Exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years and older.

Further studies are being performed to determine the long-term benefits and risks of Exjade.

Brand name: Exjade
Generic name/category: Deferasirox, Chelating agents, Orphan drugs
Company: Novartis Oncology
Country/Market: USA, North America
Indication(s)/use: chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years and older
Target: Healthcare Professionals (HCP)
Tagline: Chelate with Exjade to help remove excess iron
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – August 13, 2009

PNH is destructive, progressive, and life threatening.
What will you do?

Soliris: The power to protect.
The first humanized monoclonal antibody (MAb) to reduce hemolysis and its harmful effects in all PNH patients.

Brand name: Soliris

Generic name/category: Eculizumab, Monoclonal antibodies, Immunosuppressants
Company: Alexion Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Hemolysis reduction in Paroxysmal nocturnal haemoglobinuria (PNH)
Target: Healthcare Professionals (HCP)
Tagline: Soliris. The power to protect
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – September 24, 2009

Click on thumbnail to view the full-size ad on AdPharm

Treat his hemophelia A and… Get him in the action.

Helixate FS is an advanced recombinant factor VIII therapy.

Brand name: Helixate FS
Generic name/category: Antihemophilic Factor (Recombinant)
Company: CSL Behring
Country/Market: USA, North America
Indication(s)/use: Hemophilia
Target: Healthcare Professionals (HCP)
Tagline: Take life on
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 27, 2009

To see all of this brand’s ads on AdPharm, click here